SEARCH RESULTS
9Results for "Mederma gel 20 g/cookie"
HRA Pharma To Acquire the Mederma® Brand from Merz
Merz, a global leader in aesthetics and neurotoxins, and Laboratoire HRA Pharma SAS, a fast-growing, innovative global consumer healthcare company, announced today that they have signed an asset purchase agreement, pursuant to which HRA Pharma will acquire the global rights …
Read moreMederma® PM named a 2015 breakthrough product by total beauty
Merz Aesthetics, a division of Merz North America (US affiliate of the global Merz Pharma Group), announced today that Mederma® PM has earned an Editors’ Pick Honorable Mention in the Breakthrough Product category of the TotalBeauty.com Annual …
Read morePharmacy times and U.S. news & world report name Mederma® the #1 pharmacist recommended brand for scar and stretch mark treatments
Mederma® has been named the #1 pharmacist-recommended scar care brand for 14 years in a row. This is 2nd year that it has earned the most votes in the stretch mark treatments category. BUSINESS WIRE – Merz Aesthetics, a division …
Read morecookie
Read moreMerz Named “Top Aesthetics Company” by Aesthetic Everything® for Second Year in a Row
For the second year in a row, Merz has been recognized as the “Top Aesthetics Company” by Aesthetic Everything® and Bob Rhatigan has been named the “Top Aesthetics CEO.” As part of the annual Aesthetic and Cosmetic Medicine Awards, Merz …
Read moreMerz Aesthetics Presents Data at the IMCAS World Congress 2020
Merz Aesthetics also recognizes 10th anniversary of BOCOUTURE® (incobotulinumtoxin A) in Europe. Merz, a global leader in medical aesthetics, announced today that data on the Merz Aesthetics product portfolio, including Belotero®, Cellfina® and Radiesse® will be featured in oral and …
Read moreMerz to Present New Aesthetics Clinical Data at AMWC 2019
Merz, a global leader in aesthetics and neurotoxins, announced today that clinical data on the use of the Merz Aesthetics portfolio, including Belotero®, Cellfina®, Radiesse®, Ultherapy® and Botulinum Toxin will be featured in oral and poster presentations at the 2019 …
Read moreMerz Turns 110 and Continues its Success Story
110 years ago, on March 9, 1908, Friedrich Merz founded the Chemische Fabrik Merz & Co. in Frankfurt am Main, Germany. Today, the traditional company in Frankfurt is still family-owned, but it has evolved from a mid-sized pharmaceutical company into …
Read moreShe makes cell structures light up: Merz’ visiting professor Jennifer Lippincott-Schwartz gives an insight into the undiscovered inner of cells
Prof. Jennifer Lippincott-Schwartz was assigned to the Friedrich Merz Foundation’s Visiting Professorship, which offers topics ranging from basic research to health care research. The American cell biologist and biochemist focuses her research at the National Institute of Health on dynamic cell processes, which are directly related to a range of neurodegenerative, metabolic and cancer diseases. From October 21st to October 24th, she is giving lectures for students of medicine and life sciences at the Goethe University. One highlight of her stay is a symposium with several scientists from all over Europe to especially honor her work.
Read more